Diagnosing Alzheimer's Disease with Blood Tests
Author Information
Author(s): Nagele Eric, Han Min, DeMarshall Cassandra, Belinka Benjamin, Nagele Robert
Primary Institution: Durin Technologies, Inc.
Hypothesis
Can serum autoantibody profiles be used as diagnostic biomarkers for Alzheimer's disease?
Conclusion
The study found that specific serum autoantibodies can accurately diagnose Alzheimer's disease with high sensitivity and specificity.
Supporting Evidence
- The study identified 10 autoantibody biomarkers that differentiate Alzheimer's disease from non-demented controls with 96% sensitivity.
- These biomarkers also distinguished Alzheimer's disease from other conditions like Parkinson's disease and breast cancer.
- Random Forest analysis showed over 93% accuracy in classifying samples using the selected biomarkers.
Takeaway
Doctors can use a simple blood test to check for certain proteins that help tell if someone has Alzheimer's disease.
Methodology
The study used human protein microarrays to analyze serum samples for autoantibody expression profiles.
Potential Biases
Potential bias due to the reliance on clinical evaluations for Alzheimer's diagnosis.
Limitations
The study's sample size may not fully represent the broader population, and results need further validation with more samples.
Participant Demographics
Participants included 50 Alzheimer's disease subjects and 40 non-demented controls, with varying ages and MMSE scores.
Statistical Information
P-Value
8.03E-14
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website